This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Okayama University. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Innovations of Nagisa Sada
Introduction
Nagisa Sada is a prominent inventor based in Okayama, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as lactate dehydrogenase inhibitors. Her work has the potential to impact treatments for epilepsy and cancer.
Latest Patents
Nagisa Sada holds 2 patents. Her latest patents include a novel compound that can be used as a lactate dehydrogenase inhibitor or as an active ingredient in medicaments such as antiepileptic agents and anti-cancer agents. This compound is noted for its excellent metabolic stability. Another patent focuses on a lactate dehydrogenase inhibitor that can suppress refractory epilepsy, which is often resistant to conventional antiepileptic drugs. This inhibitor contains a compound represented by a specific formula, which includes isosafrole or related compounds.
Career Highlights
Nagisa Sada is affiliated with Okayama University, where she conducts her research and development work. Her innovative approaches in medicinal chemistry have garnered attention in the scientific community.
Collaborations
Nagisa collaborates with Tsuyoshi Inoue, who is also involved in her research endeavors.
Conclusion
Nagisa Sada's contributions to the field of medicinal chemistry through her innovative patents highlight her role as a significant inventor in the industry. Her work continues to pave the way for advancements in treatments for epilepsy and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile